Sabba Stephen L
- SEC CIK
- 0001442372
In the past year, 3 open-market sale filings worth $1.16M and no purchases.
Current role at each company
- LGND Ligand Pharmaceuticals IncDirectoras of Jun 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.16M
- 3 filings
- Net
- −$1.16M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sabba Stephen L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 (view filing) | Jun 16 | 2 days | Sabba Stephen LDirector | SSale | −2.15K | $254.00 | −$544.8K | −6.0%33.6K after | |
| Mar 25, 2026 (view filing) | Mar 23 | 2 days | Sabba Stephen LDirector | SSale | −1.00K | $207.87 | −$207.9K | −3.0%32.8K after | |
| Mar 5, 2026 (view filing) | Mar 3 | 2 days | Sabba Stephen LDirector | SSale | −2.03K | $201.50 | −$409.9K | −5.7%33.8K after | |
| Mar 7, 2024 (view filing) | Mar 5 | 2 days | Sabba Stephen LDirector | SSale | −1.89K | $74.30 | −$140.6K | −6.1%28.9K after | |
| May 12, 2023 (view filing) | May 10 | 2 days | Sabba Stephen LDirector | SSale | −6.41K | $77.13 | −$494.2K | −19.9%25.8K after |